Exp Mol Med.  2004 Dec;36(6):534-544.

Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-gamma

Affiliations
  • 1Vascular System Research Center, College of Natural Sciences Kangwon National University, Chunchon 200-701, Korea. jhahn@kangwon.ac.kr
  • 2Department of Anatomy and Cell Biology, College of Natural Sciences Kangwon National University, Chunchon 200-701, Korea.
  • 3Department of Clinical Pathology, College of Medicine, College of Natural Sciences Kangwon National University, Chunchon 200-701, Korea.
  • 4Division of Life Sciences, College of Natural Sciences Kangwon National University, Chunchon 200-701, Korea.

Abstract

During chronic inflammatory response, mono- cytes/macrophages produce 92-kDa matrix metalloproteinase-9 (MMP-9), which may contribute to their extravasation, migration and tissue remodeling. Activation of peroxisome proliferator- activated factor receptor-gamma (PPAR-gamma) has been shown to inhibit MMP-9 activity. To evaluate whether ox-LDL, a PPAR-gamma activator, inhibits PMA-induced MMP-9 expression and activity, and if so, whether CD36 and PPAR-gamma are involved in this process, we investigated the effect of ox-LDL on MMP-9 expression and activity in PMA-activated human monocytic cell line U937. PMA-induced MMP-9 expression and activity were suppressed by the treatment with ox-LDL (50 micrigram/ml) or PPAR-gamma activators such as troglitazone (5 micrometer), ciglitazone (5 micrometer), and 15d- PGJ2 (1 micrometer) for 24 h. This ox-LDL or PPAR-gamma activator-mediated inhibition of micrometer P-9 activity was diminished by the pre-treatment of cells with a blocking antibody to CD36, or PGF2a (0.3 micrometer), which is a PPAR-gamma inhibitor, as well as overexpression of a dominant-negative form of CD36. Taken together, these results suggest that ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-gamma.

Keyword

CD36; MMP-9; monocyte; ox-LDL; PMA; PPAR-gamma

MeSH Terms

Antibodies, Blocking/pharmacology
Antigens, CD36/immunology/*physiology
Cells, Cultured
Chromans/pharmacology
Gelatinase B/antagonists & inhibitors/genetics/*metabolism
Humans
Lipoproteins, LDL/pharmacology/*physiology
Monocytes/drug effects/*enzymology/metabolism
NF-kappa B/antagonists & inhibitors
PPAR gamma/*metabolism
Prostaglandin D2/*analogs & derivatives/pharmacology
RNA, Messenger/analysis/metabolism
Research Support, Non-U.S. Gov't
Tetradecanoylphorbol Acetate/antagonists & inhibitors/pharmacology
Thiazolidinediones/pharmacology
Transcription, Genetic/drug effects
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr